Prescribing trends with levalbuterol (xopenex) at a community hospital.
作者信息
Verkleeren Nicole D, Lipchick Krista M
出版信息
P T. 2009 Oct;34(10):550-3.
Abstract
摘要
相似文献
1
Prescribing trends with levalbuterol (xopenex) at a community hospital.
P T. 2009 Oct;34(10):550-3.
2
The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
J Allergy Clin Immunol. 1999 Apr;103(4):615-21. doi: 10.1016/s0091-6749(99)70233-2.
3
A levalbuterol metered-dose inhaler (Xopenex HFA) for asthma.
Med Lett Drugs Ther. 2006 Mar 13;48(1230):21-2, 24.
4
Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
Ann Allergy Asthma Immunol. 2003 Jun;90(6):583-91; quiz 591-2, 659. doi: 10.1016/S1081-1206(10)61859-5.
5
Addition of levalbuterol to a pediatric emergency department automated medication management system does not increase its use.
Int J Emerg Med. 2009 Dec 11;2(4):251-4. doi: 10.1007/s12245-009-0137-4.
6
Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
Chest. 2003 Jan;123(1):128-35. doi: 10.1378/chest.123.1.128.
7
Levalbuterol versus albuterol.
Curr Allergy Asthma Rep. 2009 Sep;9(5):401-9. doi: 10.1007/s11882-009-0058-6.
8
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Clin Ther. 2008;30 Spec No:989-1002. doi: 10.1016/j.clinthera.2008.06.010.
9
Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
J Am Osteopath Assoc. 2004 Jul;104(7):288-93.
10
Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
Am J Emerg Med. 2005 Nov;23(7):842-7. doi: 10.1016/j.ajem.2005.04.003.
本文引用的文献
1
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
J Allergy Clin Immunol. 2008 Sep;122(3):544-9. doi: 10.1016/j.jaci.2008.06.015. Epub 2008 Aug 9.
2
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Clin Ther. 2008;30 Spec No:989-1002. doi: 10.1016/j.clinthera.2008.06.010.
3
Evaluation of the efficacy and safety of levalbuterol in subjects with COPD.
COPD. 2006 Aug;3(3):125-32. doi: 10.1080/15412550600829190.
4
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
Curr Med Res Opin. 2006 Jun;22(6):1217-26. doi: 10.1185/030079906X112534.
5
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
Am J Emerg Med. 2006 May;24(3):259-67. doi: 10.1016/j.ajem.2006.01.027.
6
Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients.
Am J Health Syst Pharm. 2003 Oct 1;60(19):1971-5. doi: 10.1093/ajhp/60.19.1971.
7
Retrospective comparison of nebulized levalbuterol and albuterol for adverse events in patients with acute airflow obstruction.
Am J Ther. 2003 Sep-Oct;10(5):341-7. doi: 10.1097/00045391-200309000-00006.
8
An evaluation of nebulized levalbuterol in stable COPD.
Chest. 2003 Sep;124(3):844-9.
9
Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
Chest. 2003 Jan;123(1):128-35. doi: 10.1378/chest.123.1.128.
10
Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.
J Asthma. 2000 Jun;37(4):319-27. doi: 10.3109/02770900009055455.
Zotero 插件